and Huebner and Link (1941) demonstrated by degradation reactions, which facilitated subsequent chemical synthesis, that the haemorrhagic agent C19H1206, isolated by Campbell from toxic sweet clover, is 3, 3'-methylene-bis (4-hydroxycoumarin). Degradation with KOH revealed that 14 of the 19 carbon atoms were recoverable as salicylic acid, C7H603. The yield of salicylic acid proved to be quantitative: 7.3 mg. of the haemorrhagic agent gave 6.1 mg. of salicylic acid. Link, Overman, Sullivan, Huebner, and Scheel (1943) rationalized the possible action of dicoumarol, and were of the opinion that it must be changed chemically in the body before it acts. A schematic representation of possible degradation steps was given-viz., 3, 3'-methylene-bis (4-hydroxycoumarin) -> 3-phenyl-4-hydroxycoumarin -> 0-hydroxyacetophenone -> methyl salicylate --salicylic acid. These authors quoted unpublished work by Stahmann et al. to the effect that, of compounds structurally related to dicoumarol, only those show anticoagulant action which, theoretically, might yield salicylic acid or an O-hydroxybenzoic acid derivative on degradation. The effect of single doses of salicylic acid (10, 25, and 100 mg.) on the prothrombin time of rats, which had for one month been maintained on artificial low vitamin K rations, was convincingly demonstrated. The effect was quantitatively proportional to the dose, and was clearly evident within 16 hours of administration. On a dose of 300 mg. salicylic acid per day, rats (on low vitamin K diet) developed severe hypoprothrombinaemia in five days and died in 10 days with haemorrhagic manifestations resembling those of sweet clover disease in cattle. Further, it was shown that simultaneous administration of vitamin K prevented the appearance of haemorrhagic phenomena and the prolongation of the prothrombin time. Salicylic acid hypoprothrombinaemia could only be induced with difficulty in those species (e.g., rabbit and dog) in which experimental avitaminosis-K cannot readily be induced. However, the effect was greatly facilitated if the dogs' livers had previously been injured by prolonged chloroform anaesthesia. These authors concluded that, weight for weight, dicoumarol was 25 times more effective as an anticoagulant agent than salicylic acid, at the same time pointing out the rapid diffusion and elimination of the latter.
(average 10 secs.) on diluted (121%) plasma. Cases of cirrhosis of the liver similarly treated showed a significantly greater prolongation of prothrombin time. Acetylsalicylic acid gave substantially similar results. Vitamin K dosage (120 mg. orally and 2 mg. intramuscularly, t.d.s.) for four days, with 8 g. sodium salicylate daily, prevented the increase in prothrombin time except in a cirrhotic case which showed approximately the same increase in prothrombin time as with sodium salicylate alone. Further, it was demonstrated that the effect of dicoumarol was enhanced by sodium salicylate. Meyer and Howard (1943) also adduced evidence in confirmation of these results on human cases. With dosages of 80 gr. of aspirin daily for periods of 3 to 11 days prolongations of 2-3 seconds in prothrombin time of whole plasma were obtained. Usually the effect was discernible after one day of aspirin administration, but in most cases the maximum results were not seen until after three to four days. After cessation of the drug the prothrombin time returned to normal in two to four days. Again it was found that simultaneous administration of vitamin K obviated the effect. In view of these findings it was thought that para-amino-salicylic acid (2-hydroxy-amino-benzoic acid) might produce similar effects.
Method and Precautions Weekly determinations of prothrombin time were carried out on cases of pulmonary tuberculosis receiving 30 g. para-amino-salicylic acid daily, and on a full and varied diet throughout.
Whole blood was collected in exactly 2 ml. amounts into tubes 3 in. x 3 in. each containing the residue, after evaporation at 660 C., of 0.2 ml. of a solution of ammonium oxalate (6 g.) and potassium oxalate (4 g.) in 500 ml. distilled water. Within five hours of collection prothrombin determinations in triplicate were made on plasma so obtained, using (a) whole plasma, and (b) plasma diluted to 12{ % with normal saline. Controls from two members of the laboratory staff were used throughout for each weekly determination. For thromboplastin, powdered dried human brain was used (0.3 g. in 5.0 ml. normal saline incubated at 370 C. for 30 mins. with frequent mixing), 0.1 ml. being added to 0.1 ml. oxalated plasma, mixed, and placed in a water bath at 370 C. for one minute when 0.1 ml. M /40 calcium chloride was added, and simultaneously the stop-watch was started. Agitation was effected by smart rotation, but in the case of diluted plasma too rapid movement and frothing gave erroneous results. The dried brain used gave normal plasma prothrombin times of 13 to 17 seconds, depending on the sample (prepared from the same brain and stored in wax sealed 25 ml. screw-cap containers at 0-4°C.). All manipulations were carried out in calcium-free glassware. All pipettes before re-use were twice washed with normal saline in view of the observation of Link et al. (1943) that " a small quantity of normal plasma (or prothrombin preparation) has the capacity to restore the prothrombin time of appreciable quantities of hypoprothrombinaemic plasmas."
Concurrently with the prothrombin estimations, Kunkel (1947) tests were performed on each plasma. Results Results are tabulated as prolongations over parallel controls, the same two controls having been used throughout (Table I ). The maximal prolongations obtained on whole plasma for individual triplicate determinations were 4, 4.5, and 6 seconds; similarly for diluted (12{%) plasma the maximal prolongations (over control times) obtained were 44.5 and 52 seconds. The Kunkel test in all except four cases, who had very severe and extensive disease, showed no significant deviation from normal. The clinical significance of the prolongation of prothrombin time by P.A.S. would appear to be slight or even negligible for otherwise normal cases on full diet. The maximum prolongation obtained on whole plasma in this series-viz., 6 seconds -gave a prothrombin time of 22 seconds which, on a composite dilution curve for six normal plasmas, corresponds to 31.5% prothrombin. Spontaneous haemorrhages do not, in my experience, occur with prothrombin concentrations in excess of 10% to 15%. However, the dangers of such an occurrence must be regarded as increased where concomitant liver disease-e.g., cirrhosis or amyloid-exists. This prothrombinopenic effect of P.A.S. does not appear to be cumulative, as this was not found in patients receiving 30 g. per day for as long as three and four months. Indeed, it has been a constant feature that the small elevation of the prothrombin time, which occurs within a few days to a week of inception of P.A.S. therapy, is maintained, with minor fluctuations, throughout.
The hypothesis of Link et al., that dicoumarol may act by degradation in vivo to salicylates, does not appear to be borne out by these results. If this were true one would expect much greater prolongations of prothrombin times on such high doses as 30 g. P.A.S. per day, and on the doses of salicylates used by other investigators. Some, but only very slight, action of dicoumarol may be due to salicylate products of decomposition.
From the serial Kunkel tests, it may be said that y globulins and, indirectly, liver function were substantially unaffected by the therapy. This and the prothrombin findings accord with those of Lehmann (verbal communication) .
The prophylactic and therapeutic effects of vitamin K are well shown in the accompanying graph (Fig. 1) Grateful acknowledgment is made to Dr. D. G. Madigan, under whose care these patients were, for his generous co-operation and encouragement in this study.
